Rock Springs Capital Management as of Dec. 31, 2017
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 144 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UnitedHealth (UNH) | 4.9 | $107M | 487k | 220.46 | |
Advanced Accelerat spon ads each rep 2 ord | 3.1 | $67M | 826k | 81.62 | |
CIGNA Corporation | 3.0 | $65M | 321k | 203.09 | |
Alexion Pharmaceuticals | 2.6 | $57M | 480k | 119.59 | |
Intuitive Surgical (ISRG) | 2.4 | $53M | 144k | 364.94 | |
Pacira Pharmaceuticals (PCRX) | 2.3 | $51M | 1.1M | 45.65 | |
Merck & Co (MRK) | 2.2 | $48M | 851k | 56.27 | |
Gw Pharmaceuticals Plc ads | 2.1 | $47M | 354k | 132.01 | |
Tesaro | 2.1 | $46M | 549k | 82.87 | |
Molina Healthcare (MOH) | 2.0 | $44M | 567k | 76.68 | |
Pra Health Sciences | 2.0 | $44M | 478k | 91.07 | |
Aetna | 2.0 | $43M | 239k | 180.39 | |
Acadia Healthcare (ACHC) | 1.9 | $41M | 1.3M | 32.63 | |
Neurocrine Biosciences (NBIX) | 1.7 | $38M | 486k | 77.59 | |
Puma Biotechnology (PBYI) | 1.7 | $37M | 374k | 98.85 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.6 | $35M | 1.9M | 18.46 | |
Celgene Corporation | 1.4 | $32M | 303k | 104.36 | |
Spark Therapeutics | 1.4 | $32M | 615k | 51.42 | |
Madrigal Pharmaceuticals (MDGL) | 1.4 | $31M | 342k | 91.79 | |
Radius Health | 1.4 | $30M | 943k | 31.77 | |
Penumbra (PEN) | 1.3 | $29M | 311k | 94.10 | |
Johnson & Johnson (JNJ) | 1.3 | $28M | 200k | 139.72 | |
WellCare Health Plans | 1.2 | $27M | 134k | 201.11 | |
Loxo Oncology | 1.2 | $26M | 310k | 84.18 | |
Beigene (BGNE) | 1.2 | $26M | 266k | 97.72 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $26M | 171k | 149.86 | |
Teleflex Incorporated (TFX) | 1.0 | $23M | 92k | 248.82 | |
EXACT Sciences Corporation (EXAS) | 1.0 | $23M | 435k | 52.54 | |
Irhythm Technologies (IRTC) | 1.0 | $23M | 406k | 56.05 | |
Gilead Sciences (GILD) | 1.0 | $23M | 313k | 71.64 | |
Mersana Therapeutics (MRSN) | 1.0 | $22M | 1.3M | 16.43 | |
Edwards Lifesciences (EW) | 1.0 | $21M | 190k | 112.71 | |
Thermo Fisher Scientific (TMO) | 0.9 | $21M | 110k | 189.88 | |
Assembly Biosciences | 0.9 | $20M | 450k | 45.25 | |
Stryker Corporation (SYK) | 0.9 | $20M | 127k | 154.84 | |
Avexis | 0.9 | $19M | 175k | 110.67 | |
Insmed (INSM) | 0.9 | $19M | 614k | 31.18 | |
Medicines Company | 0.9 | $19M | 690k | 27.34 | |
Willis Towers Watson (WTW) | 0.8 | $19M | 123k | 150.69 | |
Theravance Biopharma (TBPH) | 0.8 | $18M | 653k | 27.89 | |
Galapagos Nv- (GLPG) | 0.8 | $17M | 185k | 93.76 | |
Incyte Corporation (INCY) | 0.8 | $17M | 183k | 94.71 | |
Biogen Idec (BIIB) | 0.8 | $17M | 53k | 318.57 | |
Jazz Pharmaceuticals (JAZZ) | 0.8 | $17M | 124k | 134.65 | |
Alnylam Pharmaceuticals (ALNY) | 0.8 | $17M | 130k | 127.05 | |
Epizyme | 0.8 | $17M | 1.3M | 12.55 | |
Audentes Therapeutics | 0.7 | $16M | 525k | 31.25 | |
Amarin Corporation (AMRN) | 0.7 | $16M | 4.0M | 4.01 | |
Portola Pharmaceuticals | 0.7 | $16M | 324k | 48.68 | |
Clovis Oncology | 0.7 | $16M | 232k | 68.00 | |
Wright Medical Group Nv | 0.7 | $16M | 700k | 22.20 | |
Fibrogen (FGEN) | 0.7 | $15M | 325k | 47.40 | |
Ardelyx (ARDX) | 0.7 | $15M | 2.3M | 6.60 | |
Baxter International (BAX) | 0.7 | $15M | 230k | 64.64 | |
Align Technology (ALGN) | 0.7 | $15M | 67k | 222.19 | |
Hologic (HOLX) | 0.7 | $14M | 335k | 42.75 | |
Zimmer Holdings (ZBH) | 0.7 | $14M | 119k | 120.67 | |
Sarepta Therapeutics (SRPT) | 0.7 | $14M | 258k | 55.64 | |
Anaptysbio Inc Common (ANAB) | 0.7 | $14M | 142k | 100.72 | |
Axogen (AXGN) | 0.6 | $14M | 478k | 28.30 | |
Healthsouth | 0.6 | $13M | 265k | 49.41 | |
Amicus Therapeutics (FOLD) | 0.6 | $13M | 910k | 14.39 | |
Prothena (PRTA) | 0.6 | $13M | 335k | 37.49 | |
Alder Biopharmaceuticals | 0.6 | $12M | 1.1M | 11.45 | |
Invitae (NVTAQ) | 0.5 | $12M | 1.3M | 9.08 | |
Dermira | 0.5 | $12M | 420k | 27.81 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $11M | 125k | 89.17 | |
Intersect Ent | 0.5 | $11M | 345k | 32.40 | |
Ascendis Pharma A S (ASND) | 0.5 | $11M | 280k | 40.06 | |
Blueprint Medicines (BPMC) | 0.5 | $11M | 147k | 75.41 | |
Aimmune Therapeutics | 0.5 | $11M | 293k | 37.82 | |
Juno Therapeutics | 0.5 | $11M | 230k | 45.71 | |
Odonate Therapeutics Ord | 0.5 | $10M | 410k | 25.00 | |
Aclaris Therapeutics (ACRS) | 0.5 | $10M | 415k | 24.66 | |
Rigel Pharmaceuticals | 0.4 | $9.6M | 2.5M | 3.88 | |
Inogen (INGN) | 0.4 | $9.5M | 80k | 119.08 | |
Five Prime Therapeutics | 0.4 | $9.3M | 425k | 21.92 | |
Healthequity (HQY) | 0.4 | $9.1M | 195k | 46.66 | |
Zogenix | 0.4 | $9.0M | 226k | 40.05 | |
CHINA CORD Blood Corp | 0.4 | $8.8M | 880k | 9.95 | |
Retrophin | 0.4 | $8.4M | 400k | 21.07 | |
Almost Family | 0.4 | $8.2M | 148k | 55.35 | |
Paratek Pharmaceuticals | 0.4 | $8.1M | 450k | 17.90 | |
Obseva Sa | 0.4 | $8.2M | 840k | 9.76 | |
RTI Biologics | 0.4 | $8.0M | 2.0M | 4.10 | |
Bluebird Bio (BLUE) | 0.4 | $8.0M | 45k | 178.11 | |
Ultragenyx Pharmaceutical (RARE) | 0.3 | $7.6M | 163k | 46.38 | |
Sage Therapeutics (SAGE) | 0.3 | $7.4M | 45k | 164.71 | |
Arena Pharmaceuticals | 0.3 | $7.3M | 215k | 33.97 | |
Therapeuticsmd | 0.3 | $7.1M | 1.2M | 6.04 | |
Seattle Genetics | 0.3 | $6.7M | 125k | 53.50 | |
Clearside Biomedical (CLSD) | 0.3 | $6.5M | 935k | 7.00 | |
Biohaven Pharmaceutical Holding | 0.3 | $6.6M | 244k | 26.98 | |
Clementia | 0.3 | $6.5M | 345k | 18.98 | |
Achillion Pharmaceuticals | 0.3 | $6.5M | 2.3M | 2.88 | |
Steris | 0.3 | $6.5M | 74k | 87.47 | |
Zai Lab (ZLAB) | 0.3 | $6.3M | 295k | 21.23 | |
Spero Therapeutics (SPRO) | 0.3 | $6.2M | 525k | 11.75 | |
Ablynx Nv | 0.3 | $6.2M | 250k | 24.99 | |
Tetraphase Pharmaceuticals | 0.3 | $6.0M | 950k | 6.30 | |
Adaptimmune Therapeutics (ADAP) | 0.3 | $5.8M | 875k | 6.68 | |
Global Blood Therapeutics In | 0.3 | $5.9M | 150k | 39.35 | |
DaVita (DVA) | 0.3 | $5.8M | 80k | 72.25 | |
Coherus Biosciences (CHRS) | 0.2 | $5.5M | 630k | 8.80 | |
Exelixis (EXEL) | 0.2 | $5.3M | 175k | 30.40 | |
Merus N V (MRUS) | 0.2 | $5.3M | 272k | 19.40 | |
Ra Pharmaceuticals | 0.2 | $5.1M | 600k | 8.50 | |
Heron Therapeutics (HRTX) | 0.2 | $4.5M | 250k | 18.10 | |
Medicines Company 2.750000 07/15/2023 bond | 0.2 | $4.6M | 5.0M | 0.92 | |
Corvus Pharmaceuticals (CRVS) | 0.2 | $4.4M | 423k | 10.36 | |
Macrogenics (MGNX) | 0.2 | $4.3M | 225k | 19.00 | |
Cymabay Therapeutics | 0.2 | $4.1M | 450k | 9.20 | |
G1 Therapeutics | 0.2 | $4.3M | 215k | 19.84 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $4.0M | 813k | 4.91 | |
Proteostasis Therapeutics In | 0.2 | $3.9M | 675k | 5.83 | |
Egalet Corporation note 5.50% 4/1/20 | 0.2 | $3.7M | 7.8M | 0.48 | |
Myovant Sciences | 0.2 | $3.7M | 295k | 12.64 | |
Nabriva Therapeutics | 0.2 | $3.7M | 625k | 5.98 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $3.4M | 225k | 14.99 | |
Mirati Therapeutics | 0.1 | $3.3M | 180k | 18.25 | |
Dynavax Technologies (DVAX) | 0.1 | $3.3M | 175k | 18.70 | |
Bristol Myers Squibb (BMY) | 0.1 | $3.1M | 50k | 61.28 | |
Aduro Biotech | 0.1 | $3.1M | 415k | 7.50 | |
Medicines Company conv | 0.1 | $3.2M | 3.0M | 1.06 | |
Allergan Plc pfd conv ser a | 0.1 | $2.9M | 5.0k | 586.80 | |
Aeglea Biotherapeutics | 0.1 | $2.8M | 524k | 5.41 | |
Intra Cellular Therapies (ITCI) | 0.1 | $2.7M | 188k | 14.48 | |
Novavax | 0.1 | $2.5M | 2.0M | 1.24 | |
Seres Therapeutics (MCRB) | 0.1 | $2.2M | 220k | 10.14 | |
Compugen (CGEN) | 0.1 | $2.1M | 825k | 2.50 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $2.0M | 300k | 6.80 | |
Rhythm Pharmaceuticals (RYTM) | 0.1 | $2.1M | 72k | 29.06 | |
Cardiome Pharma | 0.1 | $1.9M | 1.2M | 1.55 | |
Scynexis | 0.1 | $1.8M | 760k | 2.32 | |
Dbv Technologies S A | 0.1 | $1.8M | 73k | 24.60 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.1 | $1.7M | 475k | 3.50 | |
Alpine Immune Sciences | 0.1 | $1.7M | 150k | 11.20 | |
Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $1.7M | 1.5M | 1.10 | |
Radius Health Inc note 3.000% 9/0 | 0.1 | $1.4M | 1.5M | 0.95 | |
Wright Med Group Inc note 2.000% 2/1 | 0.1 | $1.0M | 1.0M | 1.03 | |
Chiasma | 0.0 | $893k | 525k | 1.70 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $548k | 270k | 2.03 | |
Orexigen Therapeutics | 0.0 | $213k | 165k | 1.29 | |
Dare Bioscience | 0.0 | $135k | 63k | 2.16 |